Torsemide
Edema associated with heart failure, Edema associated with renal disease, Edema associated with hepatic disease, Hypertension
Indications
- Edema associated with heart failure
- Edema associated with renal disease
- Edema associated with hepatic disease
- Hypertension
Adult dosing
- heart failure: dose: 10; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: The recommended initial dose is 10 mg or 20 mg oral torsemide tablets once daily. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 200 mg have not been adequately studied.
- renal failure: dose: 20; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: The recommended initial dose is 20 mg oral torsemide tablets once daily. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 200 mg have not been adequately studied.
- hepatic cirrhosis: dose: 5; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: The recommended initial dose is 5 mg or 10 mg oral torsemide tablets once daily, administered together with an aldosterone antagonist or a potassium-sparing diuretic. If the diuretic response is inadequate, titrate upward by approximately doubling until the desired diuretic response is obtained. Doses higher than 40 mg have not been adequately studied in this population.
- hypertension: dose: 5; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: The recommended initial dose is 5 mg once daily. If the 5 mg dose does not provide adequate reduction in blood pressure within 4 to 6 weeks, increase to 10 mg once daily.
Pediatric dosing
- Consult pharmacy/current label
Renal adjustment
- Consult pharmacy/current label
Hepatic adjustment
- Use caution in patients with hepatic disease with cirrhosis and ascites, as diuresis may precipitate hepatic coma; initiate in the hospital.
Contraindications
- Known hypersensitivity to torsemide or povidone
- Anuria
- Hepatic coma
Clinical pearls
- Monitor volume status and renal function periodically to avoid excessive diuresis and hypotension.
- Monitor serum electrolytes and blood glucose, as hypokalemia and hyperglycemia may occur.
- Ototoxicity (tinnitus, hearing loss) has been observed; risk is higher with excessive dosing and severe renal impairment.
- In patients with hepatic cirrhosis, administer with an aldosterone antagonist or potassium-sparing diuretic.
Source and review
- DailyMed label (torsemide), Set ID 5eeca7b4-92ac-bb1f-e063-6394a90a036a, effective 2026-11-09. Last reviewed: 2026-11-11
RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties